Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Ohno

Showing results (301-310 of 400) with videos related to

Pageof 40
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 1, 1984
[Treatment of hematological malignancies with recombinant leukocyte A interferon (rIFN-alpha A)]R Ohno, Y Kodera, M Ogura, et al.
Blood|April 15, 1994
A double-blind controlled study of granulocyte colony-stimulating factor started two days before induction chemotherapy in refractory acute myeloid leukemia. Kohseisho Leukemia Study GroupR Ohno, T Naoe, A Kanamaru, et al.
Blood|August 1, 1995
A randomized trial comparing interferon-alpha with busulfan for newly diagnosed chronic myelogenous leukemia in chronic phaseK Ohnishi, R Ohno, M Tomonaga, et al.
Blood|January 15, 1993
No increase of leukemia relapse in newly diagnosed patients with acute myeloid leukemia who received granulocyte colony-stimulating factor for life-threatening infection during remission induction and consolidation therapy. Japan Adult Leukemia Study GroupR Ohno, A Hiraoka, M Tanimoto, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 1, 1994
[An early phase II study of CPT-11 (irinotecan hydrochloride) in patients with hematological malignancies]R Ohno, Y Yoshida, M Oguro, et al.
Japanese Journal of Cancer Research : Gann|April 1, 1993
Clonal analysis of multiple point mutations in the N-ras gene in patients with acute myeloid leukemiaK Kubo, T Naoe, H Kiyoi, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 1, 1997
A case of Machado-Joseph disease presenting with spastic paraparesisA Kaneko, Y Narabayashi, K Itokawa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 1, 1991
[Late phase II study of MST-16 (sobuzoxane) on malignant lymphoma]K Yamada, R Ohno, T Oguri, et al.
Cancer|April 1, 1993
Treatment of adult T-cell leukemia/lymphoma with MST-16, a new oral antitumor drug and a derivative of bis(2,6-dioxopiperazine). The MST-16 Study GroupR Ohno, T Masaoka, S Shirakawa, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|November 1, 1995
[Efficacy of early administration of G-CSF after intensive chemotherapy in acute leukemia: a randomized controlled trial. Tokai Infection Study Group on Hematological Disorders]H Takeyama, H Yamada, N Emi, et al.
Pageof 40

Showing results (301-310 of 400) with videos related to

Sort By:
Pageof 40
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 1, 1984
[Treatment of hematological malignancies with recombinant leukocyte A interferon (rIFN-alpha A)]R Ohno, Y Kodera, M Ogura, et al.
Blood|April 15, 1994
A double-blind controlled study of granulocyte colony-stimulating factor started two days before induction chemotherapy in refractory acute myeloid leukemia. Kohseisho Leukemia Study GroupR Ohno, T Naoe, A Kanamaru, et al.
Blood|August 1, 1995
A randomized trial comparing interferon-alpha with busulfan for newly diagnosed chronic myelogenous leukemia in chronic phaseK Ohnishi, R Ohno, M Tomonaga, et al.
Blood|January 15, 1993
No increase of leukemia relapse in newly diagnosed patients with acute myeloid leukemia who received granulocyte colony-stimulating factor for life-threatening infection during remission induction and consolidation therapy. Japan Adult Leukemia Study GroupR Ohno, A Hiraoka, M Tanimoto, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 1, 1994
[An early phase II study of CPT-11 (irinotecan hydrochloride) in patients with hematological malignancies]R Ohno, Y Yoshida, M Oguro, et al.
Japanese Journal of Cancer Research : Gann|April 1, 1993
Clonal analysis of multiple point mutations in the N-ras gene in patients with acute myeloid leukemiaK Kubo, T Naoe, H Kiyoi, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 1, 1997
A case of Machado-Joseph disease presenting with spastic paraparesisA Kaneko, Y Narabayashi, K Itokawa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 1, 1991
[Late phase II study of MST-16 (sobuzoxane) on malignant lymphoma]K Yamada, R Ohno, T Oguri, et al.
Cancer|April 1, 1993
Treatment of adult T-cell leukemia/lymphoma with MST-16, a new oral antitumor drug and a derivative of bis(2,6-dioxopiperazine). The MST-16 Study GroupR Ohno, T Masaoka, S Shirakawa, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|November 1, 1995
[Efficacy of early administration of G-CSF after intensive chemotherapy in acute leukemia: a randomized controlled trial. Tokai Infection Study Group on Hematological Disorders]H Takeyama, H Yamada, N Emi, et al.
Pageof 40